Flovent Hfa

House dust allergy, Sneezing, Allergic Rhinitis + 22 more

Treatment

20 Active Studies for Flovent Hfa

Treatment for

House dust allergy

What is Flovent Hfa

Fluticasone propionate

The Generic name of this drug

Treatment Summary

Fluticasone propionate is a type of corticosteroid medication that is available as an inhaler, nasal spray, or topical treatment for various inflammatory conditions. It was first approved by the FDA in 1990 and has been used to treat conditions such as asthma, allergic rhinitis, and skin conditions.

Cutivate

is the brand name

image of different drug pills on a surface

Flovent Hfa Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Cutivate

Fluticasone propionate

1990

366

Effectiveness

How Flovent Hfa Affects Patients

Fluticasone propionate works by activating certain receptors in the body and reducing inflammation in the lungs of rats. When applied topically, it can also cause constriction of blood vessels in the skin.

How Flovent Hfa works in the body

Fluticasone propionate is believed to reduce inflammation in the lungs by activating certain proteins in the body. It has been shown to reduce eosinophilia, a condition marked by an overabundance of white blood cells in the lungs, in rats.

When to interrupt dosage

The endorsed dosage of Flovent Hfa is reliant upon the diagnosed circumstance, such as Sinusitis, Chronic Obstructive Pulmonary Disease (COPD) and Non-Allergic Rhinitis. The measure of dosage is contingent upon the technique of delivery (e.g. Spray, metered - Nasal or Respiratory (inhalation)) documented in the table beneath.

Condition

Dosage

Administration

prophylaxis of Allergic rhinitis

, 0.05 mg, 0.0005 mg/mg, 0.00005 mg/mg, 0.25 mg, 0.1 mg, 0.5 mg, 0.044 mg, 0.11 mg, 0.22 mg, 0.5 mg/mL, 0.05 %, 0.045 mg, 0.115 mg, 0.23 mg, 0.055 mg, 0.113 mg, 0.232 mg, 0.093 mg, 5.0 mg/mg, 2.5 mg/mg, 0.1 mg/pump actuation, 0.055 mg/pump actuation, 0.25 mg/pump actuation, 0.5 mg/pump actuation, 0.125 mg/pump actuation, 0.05 mg/pump actuation, 0.113 mg/pump actuation, 0.025 mg/pump actuation, 0.232 mg/pump actuation, 0.202 mg

, Nasal, Spray, metered, Spray, metered - Nasal, Cream - Topical, Cream, Topical, Ointment, Ointment - Topical, Respiratory (inhalation), Powder, metered - Respiratory (inhalation), Powder, metered, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Lotion - Topical, Lotion, Powder - Oral; Respiratory (inhalation), Oral; Respiratory (inhalation), Kit, Aerosol, metered; Suspension, Aerosol, metered; Suspension - Nasal, Kit - Topical, Spray, Spray - Nasal, Kit - Nasal

Bronchitis, Chronic

Eosinophilic Esophagitis

Allergy to Mold

Sinusitis

Nasal Congestion

Nose

Rhinitis

House dust allergy

Emphysema

Rhinorrhea

Hay Fever

Sinusitis

Adrenal Cortex Hormones

moderate, severe Seasonal Allergic Rhinitis

Asthma

Chronic Obstructive Pulmonary Disease

Allergy to Tree Pollen

Rhinitis, Allergic

Allergy to Animal Dander

Warnings

Flovent Hfa has five contraindications, and its use should be avoided while dealing with the conditions given in the table below.

Flovent Hfa Contraindications

Condition

Risk Level

Notes

Status Asthmaticus

Do Not Combine

Asthma

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Fluticasone Propionate may interact with Pulse Frequency

Severe Hypersensitivity Reactions

Do Not Combine

Fluticasone Propionate may interact with Pulse Frequency

Severe Hypersensitivity Reactions

Do Not Combine

Fluticasone Propionate may interact with Pulse Frequency

There are 20 known major drug interactions with Flovent Hfa.

Common Flovent Hfa Drug Interactions

Drug Name

Risk Level

Description

2-Methoxyethanol

Major

The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with 2-Methoxyethanol.

9-(N-methyl-L-isoleucine)-cyclosporin A

Major

The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.

Abemaciclib

Major

The metabolism of Abemaciclib can be decreased when combined with Fluticasone propionate.

Abetimus

Major

The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Abetimus.

Acalabrutinib

Major

The metabolism of Acalabrutinib can be decreased when combined with Fluticasone propionate.

Flovent Hfa Toxicity & Overdose Risk

Not enough research has been done to determine the safety of fluticasone propionate in certain populations. Animal studies have shown that subcutaneous fluticasone propionate may cause birth defects, but there are no reports of adverse effects with oral administration during pregnancy. Breastfeeding mothers may experience growth suppression, changes in natural cortisol levels, or other side effects. Children who use fluticasone ointment may have suppressed adrenal glands. Older adults may be more sensitive to side effects. The drug is cleared from the body at similar rates between genders and races, but those with liver disease should be closely monitored due to

image of a doctor in a lab doing drug, clinical research

Flovent Hfa Novel Uses: Which Conditions Have a Clinical Trial Featuring Flovent Hfa?

389 active trials are being conducted to assess the potential of Flovent Hfa in providing relief from Nasal Congestion, House Dust Mite Allergy and Atopic Dermatitis.

Condition

Clinical Trials

Trial Phases

Bronchitis, Chronic

0 Actively Recruiting

Asthma

92 Actively Recruiting

Phase 1, Phase 4, Early Phase 1, Phase 2, Not Applicable, Phase 3

Chronic Obstructive Pulmonary Disease

76 Actively Recruiting

Phase 3, Phase 1, Phase 2, Not Applicable, Early Phase 1, Phase 4

Sinusitis

0 Actively Recruiting

Adrenal Cortex Hormones

0 Actively Recruiting

Emphysema

4 Actively Recruiting

Phase 2, Not Applicable

Sinusitis

6 Actively Recruiting

Early Phase 1, Phase 2, Phase 3, Phase 1

House dust allergy

0 Actively Recruiting

Rhinitis, Allergic

0 Actively Recruiting

Allergy to Mold

0 Actively Recruiting

Allergy to Tree Pollen

0 Actively Recruiting

Allergic Rhinitis

0 Actively Recruiting

Nose

0 Actively Recruiting

Eosinophilic Esophagitis

0 Actively Recruiting

moderate, severe Seasonal Allergic Rhinitis

0 Actively Recruiting

Sneezing

0 Actively Recruiting

Hay Fever

0 Actively Recruiting

House Dust Mite Allergy

0 Actively Recruiting

Non-Allergic Rhinitis

0 Actively Recruiting

Atopic Dermatitis

10 Actively Recruiting

Phase 2, Phase 3, Phase 4

Flovent Hfa Reviews: What are patients saying about Flovent Hfa?

Patient Review

7/26/2012

Flovent Hfa for Late Onset Asthma

My eye doctor said that this medication caused me to develop cataracts. Not fun at all.

Patient Review

3/26/2022

Flovent Hfa for Severe Chronic Obstructed Lung Disease

One puff and I slept like the dead. Its really amazing how much better you can feel when your airways are clear. I haven't felt this good in over a year, but thanks to this treatment I'm feeling great again.

Patient Review

8/5/2013

Flovent Hfa for Asthma

This treatment stopped my constant coughing and nighttime chest tightness. It also alleviated my post-menopausal symptoms.

Patient Review

7/26/2017

Flovent Hfa for Asthma Prevention

My grandson started using Flovent 44mcg in August without much success. Doctor upped the doseage to 110mcg at the end of Oct. Now, a month later, my grandson is a different child. His asthma is under control, but his behavior is terrible. He is super hyper, has trouble sleeping, screams, cries, talks back, in addition to throwing & hitting. I've reduced him to 1 puff a day until I can get in touch with his doctor.

4.3

Patient Review

5/30/2012

Flovent Hfa for Asthma

Patient Review

12/6/2012

Flovent Hfa for Allergic Asthma

Flovent unfortunately did not work for me the way I had hoped. Not only that, but it also caused a number of terrible side effects like uncontrollable coughing, rapid heartbeat, and wheezing. It was so bad that I could barely speak and ended up with really painful leg cramps. Thankfully, I was able to stop taking this medication after just a couple of doses.

Patient Review

9/26/2014

Flovent Hfa for Allergic Asthma

My son has been taking this for about a year and a half, and while it does help control his asthma, the severe behavioral changes are becoming too much. I'm now looking into alternatives after hearing that other children have had similar side effects.

3.7

Patient Review

2/21/2014

Flovent Hfa for Asthma Prevention

Flovent has done wonders for my daughter's breathing, but unfortunately she's started to experience some pretty severe behavioral problems since starting the medication. We're currently working with her doctors to see if it's worth continuing the treatment.

3.3

Patient Review

10/8/2017

Flovent Hfa for Allergic Asthma

While this medication has helped with my asthma, I've found that it's caused some serious side effects, like hair loss and shaking hands. I'm a healthy 66-year-old, so I can't say for sure if it's the medication or not.

3.3

Patient Review

1/23/2019

Flovent Hfa for Asthma Prevention

After a few months of being on this drug, my son's behavior changed for the worse. He became depressed and angry, withdrew from everyone, and had little sleep. He also started having unsafe thoughts. We tried it for a second winter at the urging of our doctor, but it was a terrible mistake. We had to put our son on Prozac as a result.

Patient Review

4/4/2012

Flovent Hfa for Asthma Prevention

2.7

Patient Review

11/28/2012

Flovent Hfa for Asthma

I developed atrial fibrillation after using Flovent HFA and ipratropium for a year, as prescribed by my pulmonologist. I found that many other people have had similar experiences with these medications causing irregular heartbeat, hyperactivity, and insomnia. After discontinuing use of the medication, my A-Fib went away.

2.7

Patient Review

4/13/2022

Flovent Hfa for Asthma Prevention

The FDA should look into this medication, especially the effects it has on some children. After my kids started taking it, one developed psychological problems and the other had behavioral issues. They never had these problems before starting the medication. The doctors can't explain why this is occurring

2.7

Patient Review

5/7/2014

Flovent Hfa for Allergic Asthma

This has been helpful in clearing out my congestion and lungs/chest. I haven't needed to use my albuterol inhaler in about three weeks, which is great. The hoarseness I'm experiencing might resolve itself soon, fingers crossed.

2.3

Patient Review

10/6/2022

Flovent Hfa for Asthma

This had no effect whatsoever on my asthma. $200 down the drain.

1.3

Patient Review

7/14/2012

Flovent Hfa for Asthma

My three year old has been on this medication for a few months now. Since he started taking it, he's had severe night terrors and his behavior has changed drastically. The doctor says that his lungs are much clearer now, but we're going to try reducing the dosage to see if that helps with the side effects.

image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about flovent hfa

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is Flovent HFA inhaler used for?

"This is a medication for those who have asthma and are aged 4 years or older. It is not to be used for sudden breathing problems and will not replace a rescue inhaler."

Answered by AI

What is the difference between Flovent and Flovent HFA?

"HFA propellant is environmentally friendly and does not damage the Earth's ozone layer. Flovent Diskus is a powder inhaler that does not require a propellant to deliver the medication to your lungs."

Answered by AI

Is Flovent HFA a steroid?

"Flovent HFA is a steroid that is used to prevent asthma attacks. It will not help with an asthma attack that has already started."

Answered by AI

Is Flovent HFA the same as albuterol?

"Albuterol is used for quick relief of asthma symptoms, while Flovent is used to reduce inflammation and swelling of the airways over time."

Answered by AI

Clinical Trials for Flovent Hfa

Have you considered Flovent Hfa clinical trials?

We made a collection of clinical trials featuring Flovent Hfa, we think they might fit your search criteria.

Image of Stanford University in Stanford, United States.

MoblO2 for Chronic Lung Diseases

18+

All Sexes

Stanford, CA

Many patients with chronic lung disease (e.g., chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD)) require supplemental oxygen (O2) at some point during their disease course. Practitioners prescribe O2 to patients with chronic lung disease in hopes of the following: 1) that it will limit desaturation events and combat breathlessness, thus preventing the frustratingly slow pace and numerous rest breaks patients are forced to adopt while doing even simple tasks; 2) that it will allow patients to be more active physically (perhaps increase their ability to exercise) and socially (perhaps leave the home more often); 3) that it will stave off putative complications of hypoxemia (e.g., cognitive dysfunction, pulmonary hypertension) and 4) that it will improve health-related quality of life (HRQL). However, despite the rationale for O2, and prescribers' good intentions, patients generally view O2 with frustration and fear - it threatens their HRQL, which is already impaired by having a condition that imposes itself on every aspect of their lives. Nasal cannulas and delivery devices call unwanted attention to patients when they are out in public. O2 users feel stigmatized and are often viewed as "smokers who get what they deserve, even if they never smoked a day in their lives" - or as disabled, sick or even infectious. O2 steals patients' independence, forcing them to plan their lives around it. The anxiety that patients and their caregivers experience around running out of oxygen, or not getting enough, immobilizes them and restricts participation in activities outside of the home. O2 disrupts the home environment, adding stress, and creating a burden for patients' caregiver-loved-ones who are often saddled with the responsibility of ensuring adequate equipment and supply of O2, and O2 is a constant reminder to patients they are living with a condition that could shorten their lives. O2 delivery equipment is typically heavy, unwieldy and intimidating. Different recommendations (e.g., insurance companies use 88% as a cut-off for SpO2, while many practitioners focus on 90%) make it confusing for patients, which almost certainly affects adherence. O2-requiringpatients are starving for things that can make their lives easier. An auto-adjusting O2 delivery device - one that automatically delivers the correct amount of O2 to maintain blood oxygen at desired, pre-set levels - would alleviate the need for patients to constantly (incessantly for many) monitor their peripheral oxygen saturation (SpO2) and adjust O2flow to meet the demands as exertion levels vary . The MoblO2 device is a battery-operated, light-weight, closed-loop O2 delivery device that houses a regulator (which attaches to compressed gas O2 tanks) and adjusts O2 flow to meet a pre-set blood oxygen level. A pulse oximeter is worn on the ear and transmits via Bluetooth to the device, which adjusts an internal valve to control flow on a second-to-second basis. The user sets the dial to the highest flow of O2 needed to meet the demands of activities they might perform (up to 15 liters per minute), and the device adjusts flow, up to the pre-set level to maintain SpO2 at a preset level (e.g., \> 90%). To conserve O2 supply in the tank - and to avoid over-oxygenation (which could be problematic for a small percentage of patients with the most severe COPD) - the MoblO2 begins to limit O2 flow at a SpO2 of 93%. The device can be manually over-ridden by the user, and should the battery run out - or the device fail for some unforeseen reason - the default position is valve open, so the users receive whatever flow of oxygen has been set on the dial. Given the substantial burdens of O2 on patients and their families, the hassles patients describe with having to monitor their SpO2 and repeatedly adjust the flow of O2 to meet their needs, patients and experts around the world have called for improvements in O2 delivery equipment. The MoblO2 is just such a remarkable improvement and a giant step forward in helping to ease the burdens of O2 on patients who require it. The purpose of this study is to investigate the effects of the MoblO2 O2 delivery device on a range of outcomes, including physical activity, amount (liters) O2 use; maintenance of adequate SpO2 levels; patient reported outcomes including symptoms, HRQL and satisfaction with the MoblO2 O2 device.

Waitlist Available

Has No Placebo

Stanford University

Jeff Swigris, DO, MS

Minnesota Health Solutions